Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT03489031 Completed - Clinical trials for Diabetes Mellitus, Type 2

Basal Insulin And Compensation Glycemic In Diabetic Patients In Basal Bolus Outpatient.

BASAL
Start date: April 11, 2016
Phase:
Study type: Observational

Multicentric, observational, cross-sectional study in Italy. The aims are to evaluate the basal/total ratio of daily insulin dose (b/T) in diabetic outpatients type 1 (T1) and type 2 (T2) on basal-bolus regimen, by investigating whether there is a relationship with HbA1c and episodes of hypoglycemia.

NCT ID: NCT03487887 Completed - Clinical trials for Diabetes Mellitus, Type 2

Secondary Care - Continuous Glucose Monitoring

SC-COSMO
Start date: March 19, 2018
Phase:
Study type: Observational

Introduction and objective: The current state of glucose monitoring includes the use of A1C, self-monitoring of blood glucose (SMBG), and continuous glucose monitoring (CGM). CGM technology has got the potential to revolutionize diabetes care in the near future striving to optimal diabetes management and tight glucose control. Until very recently, this determination could only be achieved by the attainment of multiple capillary blood glucose determinations each day and/or measuring hemoglobin A1C. Those methods are not accurate in cases of unrecognized hypoglycemia, unrecognized nighttime events or in cases of large swings in blood glucose. Our aim is to analyze the benefit of tracking patterns of glucose values by using professional CGM technology used for "blinded" collection of glucose data retrospectively in patients with T2DM in secondary care- diabetologist clinic.

NCT ID: NCT03487029 Completed - Diabetes Clinical Trials

High-intensity Interval Training Training Protocols on Cardiorespiratory Parameters in Patients With Type 2 Diabetes

Start date: March 2, 2018
Phase: N/A
Study type: Interventional

Aim: To assess whether there are different training effects on glucose concentration and cardiorespiratory parameters of different high-intensity training protocols in patients with type 2 diabetes. Type 2 diabetes is a highly prevalent disease associated with cardiovascular disease leading to high levels of mortality, morbidity and health expenditure, characterized by impaired glucose control during activities and reduced aerobic exercise capacity . Exercise training is the most effective way to improve compliance, reduce blood glucose concentration and increase insulin sensitivity. Training increases muscle capacity, oxidative capacity and glucose transport, peripheral insulin sensitivity is improved. Exercise training with high-intensity interval (resting and exercise period) High Intensity Interval Training (HIIT) is a form of exercise training that has recently been widely used in the management of type 2 diabetes, including short duration high intensity exercise periods and lower severity or passive rest periods. There are different HIIT exercise training programs according to physiological responses in the literature. However, long-term and short-term HIIT training training programs were not compared in terms of their effect on glucose concentration and cardiorespiratory fitness. The aim of this study was to compare the effects of different HIIT exercise training programs so that exercise programs for patients with type 2 diabetes could be planned more effectively.

NCT ID: NCT03486964 Completed - Clinical trials for Diabetes Mellitus, Type 2

Use of Incretins in Diabetic Patients

Start date: March 27, 2018
Phase:
Study type: Observational

Observational, retrospective study, conducted in diabetic patients aimed to evaluate the effects on the glyco-metabolic control and on cardiovascular events of different DPP-4 inhibitors. Patients will be stratified in patients taking different DPP-4 in addition to sulfonylureas, biguanides, thiazolidinediones, insulin, compared to those in therapy with other hypoglycemic classes, such as sulphonylureas, biguanides, thiazolidinediones, insulin, alone or in combination, in primary and secondary prevention.

NCT ID: NCT03486535 Completed - Diabetes Mellitus Clinical Trials

Infraclavicular Block Properties in Diabetic Patients

Start date: February 20, 2018
Phase:
Study type: Observational

Background and objectives: The investigators are performing this study to explore whether the presence of diabetes mellitus (DM) will affect the outcomes of infraclavicular brachial plexus blocks (ICBs) in patients undergoing elbow, forearm and hand surgery. The primary hypothesis is that the sensory block duration will be delaying in diabetic patients. Methods: Ethics committee approval has been obtained and after written informed consents, 60 patients are planning to be enrolled to the study. Diabetic patients will be included in Group DM and non-diabetics are included in Group NODM. All patients will receive ultrasound-guided ICBs with the mixture of 15 mL lidocaine 2% and 15 mL bupivacaine 0.5%. Our primary outcome is sensory block duration, and secondary outcomes are sensory and motor block onset times, motor block duration, time-to-first-pain (numeric rating scale (NRS) ≥4), postoperative NRS scores and rescue analgesic consumption (NRS) ≥4) through the postoperative first 2 days. All outcomes will be assessed by blind investigators.

NCT ID: NCT03486223 Completed - Obesity Clinical Trials

Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

Start date: May 17, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test how soluble epoxide hydrolase (sEH) inhibition with GSK2256294 affects tissue sEH activity and insulin sensitivity.

NCT ID: NCT03485092 Completed - Heart Failure Clinical Trials

Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects

SUGAR-DM-HF
Start date: March 16, 2018
Phase: Phase 4
Study type: Interventional

The investigators hypothesise that empagliflozin 10mg daily will have haemodynamic, cardiac, and renal benefits compared to placebo over 36 weeks in heart failure patients with type 2 diabetes (or pre-diabetes), leading to measurable improvements in clinical measures of cardiac structure and function (LVESVI, and LV strain) as well as renal blood flow.

NCT ID: NCT03484689 Completed - Clinical trials for Diabetes Mellitus, Type 2

MBCT for DM Distress: a Pilot Qusai-experimental Study

Start date: July 14, 2018
Phase: N/A
Study type: Interventional

Background: Diabetes-related distress (DRD) is very common among people with type II diabetes mellitus (DM). DRD led to poorer DM control and may led to adverse prognosis. Yet, there is no widely accepted or recommended DRD treatment. Mindfulness was shown to relieve psychological distress in various physical and mental conditions. Aim: as a pilot project, we aim to determine if mindfulness-based cognitive therapy (MBCT), which is one of the widely used mindfulness program, is feasible and acceptable and may improve DRD in our Chinese population. Method: 20 Chinese participants with suboptimally controlled DM and high DRD will be recruited to a 8- week MBCT group. Pre-group and post-group (immediate and 2-month post-group) data including DRD score, quality-of life measures will be compared.

NCT ID: NCT03481374 Completed - Clinical trials for Diabetes Mellitus, Type 1

Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus.

Start date: July 1, 2016
Phase: N/A
Study type: Interventional

testing of autonomic function and relationship with exercise and Qol in diabetic patients and controls

NCT ID: NCT03481335 Completed - Hypertension Clinical Trials

Community Health Assessment Program in the Philippines (CHAP-P)

CHAP-P
Start date: June 1, 2018
Phase: N/A
Study type: Interventional

This study aims to evaluate the effectiveness of the Community Health Assessment Program in the Philippines (CHAP-P), looking at the differences between communities implementing CHAP-P versus communities not implementing CHAP-P.